Study evaluates biomarker criteria for assessing Alzheimer’s risk
Is a cheap ‘universal’ coronavirus vaccine on the way?
26 April 2021Why some people don’t experience vaccine side effects, and why it’s not a problem
26 April 2021Study evaluates biomarker criteria for assessing Alzheimer’s risk
One of the biggest challenges in Alzheimer’s research is to identify biomarkers that can identify people who are at risk of developing dementia. Biomarkers could be used to screen people so they might be helped before they develop dementia.
